drugset / Trial / NCT00208572

Summary

The proposal will assess the effectiveness of SRI treatment of anxiety following TBI. We hypothesize that participants will report significantly fewer and less severe anxiety symptoms after a 12-week course of citalopram than after a 12-week course of placebo.

Timeline

Start
2003-11
Primary completion
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule 40 mg